JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelso, E. J.
Right arrow Articles by Spiers, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelso, E. J.
Right arrow Articles by Spiers, J. P.

Vol. 294, Issue 3, 1047-1052, September 2000

EndothelinA Receptor Subtype Mediates Endothelin-Induced Contractility in Left Ventricular Cardiomyocytes Isolated from Rabbit Myocardium1

Elizabeth J. Kelso, Barbara J. McDermott, Bernard Silke and J. Paul Spiers

Cardiovascular Pharmacology Group, Centre for Cardiovascular Research, School of Medicine, The Queen's University of Belfast, Northern Ireland, United Kingdom

Endothelin (ET)-1 is a potent positive inotropic agent, the effects of which are mediated by increases in cytosolic Ca2+ in the myocardium. The object of this study was to examine 1) the influence of ETA and ETB receptor subtypes, and 2) the role of the phospholipase C (PLC) pathway in mediating ET-1-induced contraction. Left ventricular cardiomyocytes were isolated from the hearts of New Zealand White rabbits (2-2.5 kg) by the use of Langendorff perfusion with collagenase. Cardiomyocyte function was examined during unloaded, electrically stimulated (0.5 Hz) contractions with a video-edge detection system. ET-1 increased cell shortening with greater potency than ET-3: mean EC50 values were 1.1 × 10-11 and 2.6 × 10-10 M, respectively. With the same order of potency, ET-1 and ET-3 increased (P < .05) velocity of cell shortening. The ETA receptor-selective antagonist ABT-627 shifted the ET-1-induced cell shortening response curve to the right with a pA2 value of 10.3. The ETB receptor-selective antagonist A-192621 (10-8-10-7 M) did not alter the concentration-response of ET-1. Moreover, the ETB receptor-selective agonist sarafotoxin 6c did not have any effect on cell shortening over the concentration range of 10-11 to 10-7 M. ET-1 in the presence of the PLC inhibitor U-73122 did not alter the contractile amplitude. However, ET-1 in the presence of the protein kinase C inhibitor bisindolylmalemide increased cell shortening. These findings indicate that 1) the ETA receptor subtype, and not the ETB receptor subtype, mediates the positive inotropic effect of ET-1, and 2) the response of ET-1 is mediated by a PLC pathway, but not through protein kinase C, in ventricular cardiomyocytes isolated from rabbit myocardium.


1 This study was supported by Wellcome Trust project Grant M/95/3141.


0022-3565/00/2943-1047$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Y. Chung, M. Kang, and J. W. Walker
Contractile regulation by overexpressed ETA requires intact T tubules in adult rat ventricular myocytes
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2391 - H2399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Konrad, M. Haney, G. Johansson, M. Wanecek, E. Weitzberg, and A. Oldner
Cardiac effects of endothelin receptor antagonism in endotoxemic pigs
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H988 - H996.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Vierimaa, J. Ronkainen, H. Ruskoaho, and O. Vuolteenaho
Synergistic activation of salmon cardiac function by endothelin and beta-adrenergic stimulation
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1360 - H1370.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Bras-Silva and A. F. Leite-Moreira
Obligatory role of the endocardial endothelium in the increase of myocardial distensibility induced by endothelin-1.
Experimental Biology and Medicine, June 1, 2006; 231(6): 876 - 881.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Bras-Silva, A. P. Fontes-Sousa, C. Moura, J. C. Areias, and A. F. Leite-Moreira
Impaired Response to ETB Receptor Stimulation in Heart Failure: Functional Evidence of Endocardial Endothelial Dysfunction?
Experimental Biology and Medicine, June 1, 2006; 231(6): 893 - 898.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. C.W. Groenendijk, B. P. Hierck, J. Vrolijk, M. Baiker, M. J.B.M. Pourquie, A. C. Gittenberger-de Groot, and R. E. Poelmann
Changes in Shear Stress-Related Gene Expression After Experimentally Altered Venous Return in the Chicken Embryo
Circ. Res., June 24, 2005; 96(12): 1291 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. F. Leite-Moreira and C. Bras-Silva
Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1194 - H1199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Piuhola, M. Makinen, I. Szokodi, and H. Ruskoaho
Dual role of endothelin-1 via ETA and ETB receptors in regulation of cardiac contractile function in mice
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H112 - H118.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.